This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Investors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to Know
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should Invesco Large Cap Value ETF (PWV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PWV
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
Procter & Gamble Vs Colgate: Which is a Smarter Stock to Own Now?
by Rajani Lohia
With shifting consumer trends, digital expansion, cost cuts and tariff challenges, find out whether PG or CL is a better pick now.
Wall Street Bulls Look Optimistic About P&G (PG): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in P&G (PG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Stock Market News for Apr 25, 2025
by Zacks Equity Research
U.S. stocks closed higher on Thursday, driven by a tech rally, as investors looked for more signs of easing global trade conflict. Investors also digested a mixed bag of corporate earnings.
Procter & Gamble Meet Earnings Estimates in Q3, Organic Sales Up 1% Y/Y
by Zacks Equity Research
PG matches earnings estimates in third-quarter fiscal 2025, while sales remain soft. Organic sales grew year over year, driven by the rise in pricing.
Jobless Claims Increased in Line With Expectations
by Zacks Equity Research
Jobless Claims Increased in Line With Expectations
A Busy Morning: Jobless Claims, Durable Goods & Q1 Earnings
by Mark Vickery
While Jobless Claims and Durable Goods outperformed, we saw mixed results in Q1 earnings this morning.
Here's What Key Metrics Tell Us About P&G (PG) Q3 Earnings
by Zacks Equity Research
Although the revenue and EPS for P&G (PG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Procter & Gamble (PG) Q3 Earnings Meet Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 0% and 2.75%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Tesla, Alphabet, Boeing, Intel and Procter & Gamble
by Zacks Equity Research
Tesla, Alphabet, Boeing, Intel and Procter & Gamble are part of the Zacks top Analyst Blog.
An Uneasy Calm and 2025 Outlooks: Global Week Ahead
by John Blank
An uneasy calm has descended on investors, hopeful that the worst of the tariff-induced turmoil has passed. Wall Street shares have recovered from more than one-year lows, but are sinking again early this week.
Colgate-Palmolive (CL) Reports Next Week: What Awaits?
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
P&G (PG) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for P&G (PG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Short Week Finishes with Netflix Q1 Beat
by Mark Vickery
We'd obviously welcome any positive news on the trade tariff front over the weekend, which starts tomorrow for the markets in observance of Good Friday.
Procter & Gamble (PG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Positive Trends Powering Procter & Gamble Ahead of Q3 Earnings?
by Zacks Equity Research
PG's Q3 results are expected to reflect strong organic sales growth, driven by steady demand for daily-use products and its focus on a strong brand portfolio.
Procter & Gamble (PG) Stock Moves -1.23%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) concluded the recent trading session at $166.39, signifying a -1.23% move from its prior day's close.
Procter & Gamble (PG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the most recent trading session, Procter & Gamble (PG) closed at $169.13, indicating a +1.33% shift from the previous trading day.
Here's How You Should Play Clorox Stock After a 12% Drop in 6 Months
by Zacks Equity Research
CLX is navigating short-term pressures while leaning on its IGNITE strategy and digital transformation to spark long-term growth and shareholder value.
National Vision (EYE) Soars 9.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
National Vision (EYE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
The Zacks Analyst Blog Highlights Procter & Gamble, Novo Nordisk, PepsiCo, Genie Energy and Canterbury Park
by Zacks Equity Research
Procter & Gamble, Novo Nordisk, PepsiCo, Genie Energy and Canterbury Park are included in this Analyst Blog.